Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node‐Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy

医学 叶黄素 化疗 吉西他滨 养生 新辅助治疗 内科学 外科 胰腺切除术 肿瘤科 癌症 乳腺癌 奥沙利铂 胰腺 结直肠癌
作者
Gabriel D. Ivey,Sami Shoucair,Daniel Delitto,Joseph R. Habib,Benedict Kinny‐Köster,Christopher R. Shubert,Kelly J. Lafaro,John L. Cameron,William R. Burns,Richard A. Burkhart,Elizabeth Thompson,Amol Narang,Lei Zheng,Christopher L. Wolfgang,Jin He
出处
期刊:World Journal of Surgery [Springer Science+Business Media]
卷期号:46 (11): 2751-2759 被引量:7
标识
DOI:10.1007/s00268-022-06667-x
摘要

Abstract Background Postoperative chemotherapy following pancreatic cancer resection is the standard of care. The utility of postoperative chemotherapy for patients who receive neoadjuvant therapy (NAT) is unclear. Methods Patients who underwent pancreatectomy after NAT with FOLFIRINOX or gemcitabine‐based chemotherapy for non‐metastatic pancreatic adenocarcinoma (2015–2019) were identified. Patients who received less than 2 months of neoadjuvant chemotherapy or died within 90 days from surgery were excluded. Results A total of 427 patients (resectable, 22.2%; borderline resectable, 37.9%; locally advanced, 39.8%) were identified with the majority (69.3%) receiving neoadjuvant FOLFIRINOX. Median duration of NAT was 4.1 months. Following resection, postoperative chemotherapy was associated with an improved median overall survival (OS) (28.7 vs. 20.4 months, P = 0.006). Risk‐adjusted multivariable modeling showed negative nodal status (N0), favorable pathologic response (College of American Pathologists score 0 & 1), and receipt of postoperative chemotherapy to be independent predictors of improved OS. Regimen, duration, and number of cycles of NAT were not significant predictors. Thirty‐four percent (60/176) of node‐positive and 50.1% (126/251) of node‐negative patients did not receive postoperative chemotherapy due to poor functional status, postoperative complications, and patient preference. Among patients with node‐positive disease, postoperative chemotherapy was associated with improved median OS (27.2 vs. 10.5 months, P < 0.001). Among node‐negative patients, postoperative chemotherapy was not associated with a survival benefit (median OS, 30.9 vs. 36.9 months; P = 0.406). Conclusion Although there is no standard NAT regimen for patients with pancreatic cancer, postoperative chemotherapy following NAT and resection appears to be associated with improved OS for patients with node‐positive disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
上官若男应助帅气男孩采纳,获得30
1秒前
大力的嘉懿给大力的嘉懿的求助进行了留言
1秒前
shawn发布了新的文献求助20
1秒前
1秒前
可爱的函函应助周末万岁采纳,获得10
1秒前
wonhui发布了新的文献求助30
1秒前
绛川完成签到,获得积分10
2秒前
leeee完成签到,获得积分10
2秒前
惠惠发布了新的文献求助10
2秒前
2032jia发布了新的文献求助10
2秒前
3秒前
干净的怜珊完成签到,获得积分10
3秒前
包包琪发布了新的文献求助10
4秒前
黎明完成签到,获得积分10
5秒前
风中的青完成签到,获得积分10
5秒前
5秒前
5秒前
5秒前
ParkMoonJ完成签到,获得积分10
6秒前
赘婿应助老实天真采纳,获得10
6秒前
6秒前
洛苏发布了新的文献求助10
6秒前
亲爱的葡萄完成签到,获得积分10
7秒前
pxy完成签到,获得积分10
7秒前
KL完成签到,获得积分10
7秒前
8秒前
8秒前
bkagyin应助听话的画板采纳,获得10
8秒前
8秒前
一切随风发布了新的文献求助10
10秒前
Ai_niyou发布了新的文献求助10
10秒前
哈喽发布了新的文献求助10
10秒前
LYY发布了新的文献求助10
10秒前
杰尼龟发布了新的文献求助10
10秒前
勤劳初蓝发布了新的文献求助10
10秒前
ParkMoonJ发布了新的文献求助10
11秒前
11秒前
11秒前
月昔完成签到,获得积分10
12秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3970240
求助须知:如何正确求助?哪些是违规求助? 3514997
关于积分的说明 11176725
捐赠科研通 3250268
什么是DOI,文献DOI怎么找? 1795244
邀请新用户注册赠送积分活动 875725
科研通“疑难数据库(出版商)”最低求助积分说明 805004